Vanguard Capital Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$102M Buy
3,931,334
+42,988
+1% +$1.21M ﹤0.01% 1514
2026
Q2
$120M Buy
3,888,346
+31,621
+0.8% +$782K ﹤0.01% 1457
2026
Q1
$83.3M Buy
+3,856,725
New +$83.3M ﹤0.01% 1575

Other funds holding RCUS

Vanguard Capital Management's RCUS Position: Q3 2026 in Review

Vanguard Capital Management increased its Arcus Biosciences (RCUS) stake by 1.1% in Q3 2026, buying an estimated $1.21M and bringing the position to 3,931,334 shares worth $102M. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

Vanguard Capital Management first reported a position in RCUS in Q1 2026 and has held it in 3 quarters since. The position peaked at $120M in Q2 2026. 243 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Vanguard Capital Management held 3,931,334 shares of Arcus Biosciences worth $102M as of Q3 2026.
  • Vanguard Capital Management bought 42,988 Arcus Biosciences shares in Q3 2026, an estimated $1.21M.
  • Arcus Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1514 holding.
  • Vanguard Capital Management first reported a position in Arcus Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Arcus Biosciences position peaked at $120M in Q2 2026.
  • 243 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.